Samsara BioCapital

Samsara BioCapital LLC is a principal investment firm established in 2016 and located in Palo Alto, California. The company specializes in providing investment advisory services aimed at supporting biotechnology firms and entrepreneurs in transforming their ideas into successful ventures. It focuses on sectors such as healthcare, life sciences, oncology, and digital health, emphasizing innovation in the development of new therapies. Samsara BioCapital actively seeks to partner with ambitious and visionary companies, fostering collaboration to advance significant advancements in biotechnology.

Srinivas Akkaraju

Founder and Managing Partner

Aditya Asokan Ph.D

Senior Associate

Robert Baffi

Venture Partner

Abraham Bassan

Principal and Vice President

Mike Dybbs

Partner

Cory Freedland

Partner

Donald McCarthy

Principal

David Parry

Venture Partner

Roger Zhang Ph.D

Senior Associate

Past deals in Macau

SanReno Therapeutics

Funding Round in 2021
SanReno Therapeutics specializes in the development, manufacturing, and commercialization of therapies for kidney diseases in several regions including the People's Republic of China, Hong Kong, Macau, Taiwan, and Singapore. Established through a joint venture involving Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, the company is dedicated to researching and producing innovative biotech solutions aimed at improving the quality of life for patients suffering from kidney-related conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.